Disruption of PC1/3 expression in mice causes dwarfism and multiple neuroendocrine peptide processing defects.
about
Abnormal expression and processing of the proprotein convertases PC1 and PC2 in human colorectal liver metastasesRegulation of the hypothalamic thyrotropin releasing hormone (TRH) neuron by neuronal and peripheral inputsThe cell-specific pattern of cholecystokinin peptides in endocrine cells versus neurons is governed by the expression of prohormone convertases 1/3, 2, and 5/6Furin at the cutting edge: from protein traffic to embryogenesis and diseaseEngineering the gut for insulin replacement to treat diabetes60 YEARS OF POMC: Biosynthesis, trafficking, and secretion of pro-opiomelanocortin-derived peptidesObesity genetics in mouse and human: back and forth, and back againThe association of common variants in PCSK1 with obesity: a HuGE review and meta-analysisPhysiology of proglucagon peptides: role of glucagon and GLP-1 in health and diseaseRegulation of regional expression in rat brain PC2 by thyroid hormone/characterization of novel negative thyroid hormone response elements in the PC2 promoterFunctional consequences of a novel variant of PCSK1Metabolic and Behavioural Phenotypes in Nestin-Cre Mice Are Caused by Hypothalamic Expression of Human Growth HormoneDifferential regulation of prohormone convertase 1/3, prohormone convertase 2 and phosphorylated cyclic-AMP-response element binding protein by short-term and long-term morphine treatment: implications for understanding the "switch" to opiate addictIntracellular trafficking of thyroid peroxidase to the cell surfaceCathepsin L participates in the production of neuropeptide Y in secretory vesicles, demonstrated by protease gene knockout and expressionNeutral sphingomyelinase 2 (smpd3) in the control of postnatal growth and developmentInhibition of deoxyhypusine synthase enhances islet {beta} cell function and survival in the setting of endoplasmic reticulum stress and type 2 diabetesThe multifaceted proprotein convertases: their unique, redundant, complementary, and opposite functionsMice deficient for glucagon gene-derived peptides display normoglycemia and hyperplasia of islet {alpha}-cells but not of intestinal L-cellsDefective transport of the obesity mutant PC1/3 N222D contributes to loss of function.Role of PCSK5 expression in mouse ovarian follicle development: identification of the inhibin α- and β-subunits as candidate substrates.Analysis of peptides in prohormone convertase 1/3 null mouse brain using quantitative peptidomics.Intraislet production of GLP-1 by activation of prohormone convertase 1/3 in pancreatic α-cells in mouse models of ß-cell regeneration.Severe block in processing of proinsulin to insulin accompanied by elevation of des-64,65 proinsulin intermediates in islets of mice lacking prohormone convertase 1/3.Modulation of prohormone convertase 1/3 properties using site-directed mutagenesis.What lies ahead for the proprotein convertases?Deletion of the gene encoding proprotein convertase 5/6 causes early embryonic lethality in the mouseThe dwarf phenotype in GH240B mice, haploinsufficient for the autism candidate gene Neurobeachin, is caused by ectopic expression of recombinant human growth hormone.Pax6 directly down-regulates Pcsk1n expression thereby regulating PC1/3 dependent proinsulin processing.Impaired enteroendocrine development in intestinal-specific Islet1 mouse mutants causes impaired glucose homeostasis.The effects of fluorouracil, epirubicin, and cyclophosphamide (FEC60) on the intestinal barrier function and gut peptides in breast cancer patients: an observational study.MAFA controls genes implicated in insulin biosynthesis and secretionSmall-intestinal dysfunction accompanies the complex endocrinopathy of human proprotein convertase 1 deficiency.Proprotein convertase 1/3 (PC1/3) in the rat alveolar macrophage cell line NR8383: localization, trafficking and effects on cytokine secretion.Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells.Ablation of the glucagon receptor gene increases fetal lethality and produces alterations in islet development and maturationThe role of incretins in glucose homeostasis and diabetes treatment.Adventures with insulin in the islets of LangerhansHypothalamic proopiomelanocortin processing and the regulation of energy balanceDysgenesis of enteroendocrine cells in Aristaless-Related Homeobox polyalanine expansion mutations.
P2860
Q21261225-F0859591-7E67-4B7F-8E6B-4538E46CEFD5Q24604140-6E2700B7-8A40-41FD-A9A9-31F96011A39CQ24645350-F2A4121C-1CD8-49A8-A669-62C4A121E9AAQ24670432-839309DC-0B0A-45AF-A7CA-431642E6F21EQ26749174-004C0A37-37B2-4AF8-9179-E092848C1CEFQ26765954-115CBE6E-3253-4317-A10F-12EE40BA668EQ26782027-867393F8-C94E-4A53-BC35-D466E31524C3Q27001166-0BDBC076-F5AF-4ADD-B5A6-99978368BBB6Q27027920-8478D729-5C25-422C-AAD1-7F6494CA7EA3Q28297247-BB019CA2-C9BD-4956-8749-BF1CFE56E816Q28485317-B746209E-603D-46F5-976D-4B3C482BAB8DQ28547258-2CC9A1D0-0092-4C5C-B7EF-22FCD53D41A5Q28566109-63348783-AF03-4D40-9DB0-E4BB725158E6Q28575656-1CE699EC-1DD8-4CDB-A427-97FAC9AD84D7Q28580256-5E5212E4-0733-42E7-9EC9-9BBF4991F9E9Q28595054-C8F9811F-6D64-4152-A1A0-C78229A15DFEQ30429251-224E5F56-8DC0-4C66-953B-D3008F4B58B3Q30541820-EE20AFFD-7D14-4AA4-8156-4A14F67A8D05Q33642038-74C5626F-4D6B-4239-98C3-5E19AE7B9C40Q33765468-D30DD19A-FD6A-4B67-A495-88A4598F59A9Q33847607-3F0CB32D-8027-446C-87DB-E19D934E605CQ33965305-16A0E378-8C75-45F8-A47C-A43323B16541Q34012946-54B46372-73FF-4AE9-8D92-BA3A4F182554Q34074254-77A62D10-42DB-4D5F-AFBA-30306CB82B73Q34132292-30144356-C1E5-4A61-8AE0-4F5B3FCD51D7Q34169463-C4E7A0A6-89B6-4126-B876-DB2048058727Q34233493-A914203C-35FF-4DB4-A694-C9FF92118E70Q34343659-32F9C78C-72A4-4B24-9E04-13CCC4B72887Q34442538-FDC4CC25-7282-4AB8-BC43-BA3529D56A66Q34519292-596015CB-715A-4107-84E2-52C3EF6C9732Q34573812-7FB3F702-ABB0-4F89-AB59-8B0B175EF015Q34588075-3ADBB477-7283-48A6-BBBD-95B63B6954A8Q34649087-F5499A08-C5B9-4FDC-8859-B86115F5EDB7Q34700397-1B5080D0-A137-4897-82CD-0A359805BDE4Q34857481-59D4BC4E-A833-4543-935A-F57783EAA834Q34871133-FB0FF638-161F-4DBC-8303-DD0617923454Q34901533-E1052A57-E6B0-4880-87D1-3EC71F4354E9Q34978853-CC24E96F-6BDB-4839-9314-85A2F61515BAQ34984890-94ABDB62-B86E-44EB-B442-7215CB7BCCFFQ35019818-EB9C0EC1-F40C-4AC0-BA89-B3325BF97BE2
P2860
Disruption of PC1/3 expression in mice causes dwarfism and multiple neuroendocrine peptide processing defects.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Disruption of PC1/3 expression ...... ne peptide processing defects.
@ast
Disruption of PC1/3 expression ...... ne peptide processing defects.
@en
Disruption of PC1/3 expression ...... ne peptide processing defects.
@nl
type
label
Disruption of PC1/3 expression ...... ne peptide processing defects.
@ast
Disruption of PC1/3 expression ...... ne peptide processing defects.
@en
Disruption of PC1/3 expression ...... ne peptide processing defects.
@nl
prefLabel
Disruption of PC1/3 expression ...... ne peptide processing defects.
@ast
Disruption of PC1/3 expression ...... ne peptide processing defects.
@en
Disruption of PC1/3 expression ...... ne peptide processing defects.
@nl
P2093
P2860
P356
P1476
Disruption of PC1/3 expression ...... ne peptide processing defects.
@en
P2093
Arunangsu Dey
Christina Norrbom
Chunling Zhang
Donald F Steiner
Iris Lindberg
Randi Ugleholdt
Raymond Carroll
Virginie Laurent
Xiaorong Zhu
P2860
P304
10293-10298
P356
10.1073/PNAS.162352599
P407
P577
2002-07-26T00:00:00Z